Would selenium supplementation aid in therapy for Chagas Disease?

Trends in Parasitology

Volumn 27, Issue 3, 2011, Pages 102-105

  Jelicks, Linda A ^a   de Souza, Andréa P ^b   Araújo Jorge, Tania C ^b   Tanowitz, Herbert B ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BENZNIDAZOLE; NIFURTIMOX; POSACONAZOLE; SE METHYLSELENOCYSTEINE; SEL PLEX; SELENATE; SELENIUM; SODIUM SELENITE; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ANTIOXIDANT ACTIVITY; CARDIOMYOPATHY; CHAGAS DISEASE; DRUG EFFICACY; ECHOCARDIOGRAPHY; HUMAN; IMMUNE RESPONSE; NONHUMAN; OXIDATIVE STRESS; PHASE 3 CLINICAL TRIAL (TOPIC); REVIEW; TRYPANOSOMA CRUZI;

ANIMALS; ANTIOXIDANTS; CHAGAS CARDIOMYOPATHY; CHAGAS DISEASE; CHEMOTHERAPY, ADJUVANT; DISEASE PROGRESSION; HUMANS; MICE; SELENIUM; TREATMENT OUTCOME;

TRYPANOSOMA CRUZI;

EID: 79952103084     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2010.12.002     Document Type: Review

References (41)

1. Clayton J. Chagas disease 101. Nature 2010, 465:S4-5.
2. Pinazo M.J., et al. Successful treatment with posaconazole of a patient with chronic Chagas disease and systemic lupus erythematosus. Am. J. Trop. Med. Hyg. 2010, 82:583-587.
3. Clayton J. Chagas disease: pushing through the pipeline. Nature 2010, 465:S12-15.
4. Soares M.B., Santos R.R. Current status and perspectives of cell therapy in Chagas disease. Mem. Inst. Oswaldo Cruz. 2009, 104(Suppl. 1):325-332.
5. Garcia R.L., et al. Surgical treatment of Chagas megacolon. Critical analysis of outcome in operative methods. Acta Cir. Bras. 2008, 23(Suppl. 1):83-92. discussion 92.
6. Ribeiro C.M., et al. Antioxidant therapy attenuates oxidative insult caused by benzonidazole in chronic Chagas' heart disease. Int. J. Cardiol. 2009, 145:27-33.
7. Macao L.B., et al. Antioxidant therapy attenuates oxidative stress in chronic cardiopathy associated with Chagas' disease. Int. J. Cardiol. 2007, 123:43-49.
8. de Oliveira T.B., et al. Oxidative stress in chronic cardiopathy associated with Chagas disease. Int. J. Cardiol. 2007, 116:357-363.
9. Perez-Fuentes R., et al. Severity of chronic Chagas disease is associated with cytokine/antioxidant imbalance in chronically infected individuals. Int. J. Parasitol. 2003, 33:293-299.
10. Garg N. Mitochondrial disorders in chagasic cardiomyopathy. Front Biosci. 2005, 10:1341-1354.
11. Zacks M.A., et al. An overview of chagasic cardiomyopathy: pathogenic importance of oxidative stress. An Acad. Bras. Cienc. 2005, 77:695-715.
12. Stadtman T.C. Selenocysteine. Ann. Rev. Biochem. 1996, 65:83-100.
13. Gabrashanska M., et al. Selenium supplementation at low doses contributes to the antioxidant status in Trichinella spiralis-infected rats. Parasitol. Res. 2010, 106:561-570.
14. Arthur J.R., et al. Selenium in the immune system. J. Nutr. 2003, 133:1457S-1459S.
15. Desowitz R.S., Barnwell J.W. Effect of selenium and dimethyl dioctadecyl ammonium bromide on the vaccine-induced immunity of Swiss-Webster mice against malaria (Plasmodium berghei). Infect. Immun. 1980, 27:87-89.
16. Pilarczyk B., et al. Selenium supplementation enhances the protective response to Toxocara canis larvae in mice. Parasite Immunol. 2008, 30:394-402.
17. Sepulveda R.T., et al. Selenium supplementation decreases coxsackievirus heart disease during murine AIDS. Cardiovasc. Toxicol. 2002, 2:53-61.
18. Ilback N.G., et al. Effects of selenium supplementation on virus-induced inflammatory heart disease. Biol. Trace Elem. Res. 1998, 63:51-66.
19. Chen C., et al. Effect of selenium supplementation on mice infected with LP-BM5 MuLV, a murine AIDS model. Biol. Trace Elem. Res. 1997, 59:187-193.
20. Huang K., Yang S. Inhibitory effect of selenium on Cryptosporidium parvum infection in vitro and in vivo. Biol. Trace Elem. Res. 2002, 90:261-272.
21. Yu L., et al. Protection from H1N1 influenza virus infections in mice by supplementation with selenium: a comparison with selenium-deficient mice. Biol. Trace Elem. Res. 2010, 10.1007/s12011-010-8726-x.
22. Li W., Beck M.A. Selenium deficiency induced an altered immune response and increased survival following influenza A/Puerto Rico/8/34 infection. Exp. Biol. Med. (Maywood) 2007, 232:412-419.
23. Beck M.A., et al. Selenium deficiency increases the pathology of an influenza virus infection. FASEB J. 2001, 15:1481-1483.
24. Beck M.A., et al. Benign human enterovirus becomes virulent in selenium-deficient mice. J. Med. Virol. 1994, 43:166-170.
25. Wang C., et al. Induced susceptibility of host is associated with an impaired antioxidant system following infection with Cryptosporidium parvum in Se-deficient mice. PLoS One 2009, 4:e4628.
26. Wang C., et al. Selenium deficiency impairs host innate immune response and induces susceptibility to Listeria monocytogenes infection. BMC Immunol. 2009, 10:55.
27. McCarthy S.M., Davis C.D. Prooxidant diet provides protection during murine infection with Toxoplasma gondii. J. Parasitol. 2003, 89:886-894.
28. Rivera M.T., et al. Progressive Chagas' cardiomyopathy is associated with low selenium levels. Am. J. Trop. Med. Hyg. 2002, 66:706-712.
29. de Souza A.P., et al. Trypanosoma cruzi: host selenium deficiency leads to higher mortality but similar parasitemia in mice. Exp. Parasitol. 2002, 101:193-199.
30. Gomez R.M., et al. Host selenium deficiency increases the severity of chronic inflammatory myopathy in Trypanosoma cruzi-inoculated mice. J. Parasitol. 2002, 88:541-547.
31. de Souza A.P., et al. Selenium supplementation at low doses contributes to the decrease in heart damage in experimental Trypanosoma cruzi infection. Parasitol. Res. 2003, 91:51-54.
32. Davis C.D., et al. Beneficial effect of selenium supplementation during murine infection with Trypanosoma cruzi. J. Parasitol. 1998, 84:1274-1277.
33. Korpela H., et al. Effect of selenium supplementation after acute myocardial infarction. Res. Commun. Chem. Pathol. Pharmacol. 1989, 65:249-252.
34. Saito Y., et al. Effect of selenium deficiency on cardiac function of individuals with severe disabilities under long-term tube feeding. Dev. Med. Child Neurol. 1998, 40:743-748.
35. Foster L.H., Sumar S. Selenium in health and disease: a review. Crit. Rev. Food Sci. Nutr. 1997, 37:211-228.
36. Reeves W.C., et al. Reversible cardiomyopathy due to selenium deficiency. JPEN J. Parenter Enteral Nutr. 1989, 13:663-665.
37. Saliba W., et al. Heart failure secondary to selenium deficiency, reversible after supplementation. Int. J. Cardiol. 2010, 141:e26-27.
38. Souza A.P., et al. The benefits of using selenium in the treatment of Chagas disease: prevention of right ventricle chamber dilatation and reversion of Trypanosoma cruzi-induced acute and chronic cardiomyopathy in mice. Mem. Inst. Oswaldo Cruz 2010, 105:746-751.
39. de Souza A.P., et al. Magnetic resonance imaging in experimental Chagas disease: a brief review of the utility of the method for monitoring right ventricular chamber dilatation. Parasitol. Res. 2005, 97:87-90.
40. de Souza A.P., et al. The role of selenium in intestinal motility and morphology in a murine model of Trypanosoma cruzi infection. Parasitol. Res. 2010, 106:1293-2129.
41. Food and Nutrition Board, Institute of Medicine (2000) Selenium. In Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids, pp. 284-324, National Academy Press.